Is Wegovy only an appetite suppressant, or does it do more?

Does Wegovy just turn down a hunger dial?

The short answer is no. Calling Wegovy purely an appetite suppressant is a bit like calling a car a seat — technically part of it, but not the whole thing. Semaglutide binds to GLP-1 receptors, which exist throughout the body: in the hypothalamus (the brain region that governs appetite and energy balance), in the gut wall, and in the pancreas. Each binding site contributes something distinct.

In the brain, GLP-1 receptor activation reduces the drive to eat and can dampen the reward signals that make highly palatable food feel particularly compelling. Many people on Wegovy report that the pull towards crisps, chocolate or a second portion simply weakens, not because they are forcing themselves, but because the craving is quieter. That is the appetite-suppression element, and it is real.

But there is more going on beneath that. Wegovy's full mechanism involves gastric motility and hormonal signalling that operate whether or not you are consciously feeling hungry. Understanding the distinction matters, because it explains why people lose weight at different rates and why the medicine requires proper clinical oversight rather than a one-size approach. If you are wondering whether Wegovy is an appetite suppressant, the honest answer is that it influences appetite as one part of a broader picture, not as its sole effect. The question of how Wegovy suppresses appetite only tells part of this story.

What does slowed gastric emptying actually change day-to-day?

One of Wegovy's most practically significant effects is gastric slowing: food moves from the stomach into the small intestine more gradually than usual. The result is that a smaller meal produces a longer-lasting sense of fullness. You might eat lunch and find you are simply not interested in dinner at the usual time, not because of a conscious decision, but because your stomach is still processing the earlier meal.

This effect also partly explains the nausea that some people experience, particularly in the early weeks and after dose increases. The stomach is adjusting to a slower rhythm. According to the NHS medicines page for semaglutide, nausea, vomiting and constipation are among the most commonly reported side effects, and they tend to ease as the body adapts.

Practically, this changes how you approach meals. Eating more slowly, choosing smaller portions and avoiding very fatty foods that sit heavily can make the adjustment smoother. Our guide to eating well on Wegovy goes into the dietary detail. Worth knowing: some people find the gastric effect varies slightly across the week, being more noticeable in the day or two after the weekly injection.

Is there a difference between appetite and food cravings, and does Wegovy affect both?

Yes, and the distinction is clinically meaningful. Appetite is the physiological drive to eat, hunger triggered by falling blood glucose, ghrelin release, an empty stomach. Cravings are more psychological, shaped by memory, reward pathways and habit. They can occur even when you are physically full. The two systems overlap but they are not the same.

Evidence from the STEP 1 trial, published in the New England Journal of Medicine, showed that adults using semaglutide 2.4mg alongside lifestyle changes lost an average of around 15% of body weight over 68 weeks, significantly more than lifestyle changes alone. That level of effect is hard to explain through appetite reduction alone. Researchers believe the dampening of food-reward signalling in the brain's mesolimbic system (the pathway behind craving) plays a meaningful role.

If you find yourself still feeling hungry on Wegovy, it does not necessarily mean the medicine is not working; the craving pathway and the hunger pathway can respond at different rates and to different extents between individuals.

So what does this mean for how to use Wegovy well?

Knowing that Wegovy does more than suppress appetite has practical implications. The reduced craving effect means some people eat significantly less without consciously trying to, which is clinically useful, but also means protein and nutrient intake can quietly drop. Maintaining adequate protein, staying hydrated and keeping up some physical activity remain important alongside treatment, not as willpower exercises but because the body still needs those inputs to manage muscle mass and general health.

These are conversations a prescriber should be having with you before and during treatment. At nume, a GPhC-registered Independent Prescriber reads every consultation personally; there is no automated triage. Once clinically approved, your treatment is dispatched the same day if you order before 12pm, arriving via DPD in plain, unbranded packaging the next working day. The cost of private treatment varies by dose and provider, our Wegovy price comparison page sets out the honest context. If you'd like to understand whether Wegovy is clinically suitable for you, start your free consultation and our prescribers will review your answers the same day.